Cargando…

FMRP modulates the Wnt signalling pathway in glioblastoma

Converging evidence indicates that the Fragile X Messenger Ribonucleoprotein (FMRP), which absent or mutated in Fragile X Syndrome (FXS), plays a role in many types of cancers. However, while FMRP roles in brain development and function have been extensively studied, its involvement in the biology o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pedini, Giorgia, Buccarelli, Mariachiara, Bianchi, Fabrizio, Pacini, Laura, Cencelli, Giulia, D’Alessandris, Quintino Giorgio, Martini, Maurizio, Giannetti, Stefano, Sasso, Franceschina, Melocchi, Valentina, Farace, Maria Giulia, Achsel, Tilmann, Larocca, Luigi M., Ricci-Vitiani, Lucia, Pallini, Roberto, Bagni, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388540/ https://www.ncbi.nlm.nih.gov/pubmed/35982038 http://dx.doi.org/10.1038/s41419-022-05019-w

Ejemplares similares

Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood–Brain Barrier
por: Pacioni, Simone, et al.
Publicado: (2019)

Glioblastoma endothelium drives bevacizumab‐induced infiltrative growth via modulation of PLXDC1
por: Falchetti, Maria Laura, et al.
Publicado: (2018)

Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis
por: Buccarelli, Mariachiara, et al.
Publicado: (2018)

A three‐microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes
por: Marziali, Giovanna, et al.
Publicado: (2017)

Dilation of Brain Veins and Perivascular Infiltration by Glioblastoma Cells in an In Vivo Assay of Early Tumor Angiogenesis
por: D'Alessandris, Quintino Giorgio, et al.
Publicado: (2021)

Elesclomol-induced increase of mitochondrial reactive oxygen species impairs glioblastoma stem-like cell survival and tumor growth
por: Buccarelli, Mariachiara, et al.
Publicado: (2021)

Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
por: Ceruti, Tommaso, et al.
Publicado: (2022)

Short tandem repeat profiling for the authentication of cancer stem‐like cells
por: Visconti, Paola, et al.
Publicado: (2020)

Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts
por: Pacioni, Simone, et al.
Publicado: (2017)

Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical Treatments
por: Grande, Sveva, et al.
Publicado: (2022)

Deregulated expression of the imprinted DLK1-DIO3 region in glioblastoma stemlike cells: tumor suppressor role of lncRNA MEG3
por: Buccarelli, Mariachiara, et al.
Publicado: (2020)

Effects of the Combined Treatment with a G-Quadruplex-Stabilizing Ligand and Photon Beams on Glioblastoma Stem-like Cells: A Magnetic Resonance Study
por: Palma, Alessandra, et al.
Publicado: (2021)

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
por: Martini, Maurizio, et al.
Publicado: (2018)

Characterization of Glioblastoma Cells Response to Regorafenib
por: Mongiardi, Maria Patrizia, et al.
Publicado: (2022)

Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
por: Marziali, G., et al.
Publicado: (2016)

Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1
por: Lulli, Valentina, et al.
Publicado: (2020)

Glioblastoma-Specific Strategies of Vascularization: Implications in Anti-Angiogenic Therapy Resistance
por: Buccarelli, Mariachiara, et al.
Publicado: (2022)

Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome
por: Cesarini, Valeriana, et al.
Publicado: (2017)

miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal
por: Lulli, Valentina, et al.
Publicado: (2015)

FMRP expression in primary breast tumor cells correlates with recurrence and specific site of metastasis
por: Caredda, E., et al.
Publicado: (2023)

Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression
por: Papale, Marco, et al.
Publicado: (2020)

Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth
por: Sighel, Denise, et al.
Publicado: (2021)

Biomarkers for glioblastoma multiforme: status quo
por: Montano, Nicola, et al.
Publicado: (2016)

Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals
por: Cencelli, Giulia, et al.
Publicado: (2023)

BC1-FMRP interaction is modulated by 2′-O-methylation: RNA-binding activity of the tudor domain and translational regulation at synapses
por: Lacoux, Caroline, et al.
Publicado: (2012)

MiR-378a-3p Acts as a Tumor Suppressor in Colorectal Cancer Stem-Like Cells and Affects the Expression of MALAT1 and NEAT1 lncRNAs
por: Castellani, Giorgia, et al.
Publicado: (2022)

A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology
por: Tate, Courtney M., et al.
Publicado: (2015)

The FMRP regulon: from targets to disease convergence
por: Fernández, Esperanza, et al.
Publicado: (2013)

Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)

Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like Cells
por: Dini, Valentina, et al.
Publicado: (2023)

Sm-like proteins in the pathogenesis of Spinal Muscular Atrophy
por: Achsel, Tilmann, et al.
Publicado: (2015)

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2018)

Protein synthesis levels are increased in a subset of individuals with fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2018)

Molecular Analysis in a Glioblastoma Cohort—Results of a Prospective Analysis
por: Lauretti, Liverana, et al.
Publicado: (2022)

5-Aminolevulinic Acid (5-ALA)-Induced Protoporphyrin IX Fluorescence by Glioma Cells—A Fluorescence Microscopy Clinical Study
por: Pacioni, Simone, et al.
Publicado: (2022)

The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells
por: Zalfa, Francesca, et al.
Publicado: (2017)

Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts
por: Pacioni, Simone, et al.
Publicado: (2015)

Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study
por: Di Bonaventura, Rina, et al.
Publicado: (2023)

Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs
por: Grande, Sveva, et al.
Publicado: (2018)

Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review
por: D’Alessandris, Quintino Giorgio, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q0n6061eai4lpvb6urlq19bopd